The Down Syndrome Research and Treatment Foundation is dedicated to finding a treatment to improve cognition including learning, memory and speech for individuals with Down syndrome. Since our founding in 2004 we have become the leading private source of funding in the United States for Down syndrome cognition research. Read about our results.
May is for Celebrating Mom with DSRTF
We each know mothers who give their children the most precious gifts there are: unconditional love, unflagging advocacy, and a commitment to giving them their best chance for fulfillment.
Mother's Day may be over, but through the end of May we're offering you the chance to show these remarkable women how much you appreciate them by giving a gift in their honor. Your donation supports urgent biomedical research that will enable their children to participate more successfully in school; lead more active and independent lives; and avoid the early onset of Alzheimer's disease.
This is a distinctive, personal way to give your admiration of the special mothers, grandmothers, and wives in your life a tangible form — and to signal your shared dedication to building a secure, successful future for the children we all cherish.
Donations of $1,000 and more will be matched 1:1 thanks to a generous challenge gift. Please select "Mother's Day 2013" on our donation form to ensure proper attribution.
Webinar Recording: Down Syndrome Cognition Research 101
Scientists used to think the intellectual disability conferred by Down syndrome was too complex to treat. But thanks to the enormous strides researchers have made, we now believe that it's not only possible to improve cognition through drug treatment, but that the goal of improved learning, memory, and speech for people with DS may be within reach.
In this special World Down Syndrome Day event we introduced the basics of cognition research, discussed current research initiatives, and reported on clinical trials now underway. Presenters from DSRTF and Roche, the global health care company, offered an informative, accessible presentation appropriate for those new to the topic, and answered audience questions. Our thanks to those who participated. Review the recording here.
NIH Announces Down Syndrome Patient Registry
We're gratified and excited to pass along the NIH's announcement that it will fund the development of a national registry specifically for people with Down syndrome. This centralized information clearinghouse will facilitate communication among families, researchers, clinicians, and patient groups, and will be crucial, says DSRTF's Chief Scientific Officer Dr. Michael Harpold, to facilitating and supporting new clinical studies and trials for the benefit of people with DS. We look forward to the enhanced information sharing it will allow, and we thank the NIH for its continued service to the DS community. Read more at the plus15 Blog.
Announcing the 2012-2013 Recipients of DSRTF Research Grants
Each year, in keeping with our mission to further progress towards treatments to improve learning, memory, and speech in people with Down syndrome, DSRTF offers funding opportunities to scientists working in the field of cognition research — work that would not be possible, say researchers, without DSRTF’s support. We thank these exceptional investigators for their dedication and innovation, and are proud to announce our material support of their efforts.
Roche's groundbreaking clinical trials
Global health care company Roche continues its landmark investigations into therapies for Down syndrome with its ongoing clinical trials. Learn more about these efforts, and find out how to participate.